Funding Opportunities
NEW !!
2024-2025 Liquid Biopsy Request For Proposals
The Brain Tumor Funders’ Collaborative aims to fund projects that will accelerate liquid biopsy technology for brain tumors. Our goal is to help the scientific community make liquid biopsy a viable option for pediatric, adolescent and young adult (AYA), and adult brain tumor patient care.
To this end we seek Letters of Intent for multi-institutional, multi-disciplinary team-based projects, in the amount of $500,000 over a two-year period. The total funding available for this grant cycle is estimated at $1,000,000. Letters of Intent are due January 16, 2025.
Please email grants@abta.org if you have any questions.
RFP focused on liquid biopsy for brain tumors.
RFP focused on liquid biopsy for brain tumors.

Past Funding Opportunities
Past Funding Opportunities

2018 RFP: Immunotherapy for Primary Human Brain Tumors
2018 RFP: Immunotherapy for Primary Human Brain Tumors

2013 RFP: Comprehensive Evaluation of Long-term Survivors of GBM
2013 RFP: Comprehensive Evaluation of Long-term Survivors of GBM

2009 RFP: New Approaches for Developing Tools for Non-Invasive or Minimally-Invasive Monitoring of Pediatric and Adult Gliomas
2009 RFP: New Approaches for Developing Tools for Non-Invasive or Minimally-Invasive Monitoring of Pediatric and Adult Gliomas

2005 RFP: New Mechanisms for Preclinical Development and Testing of Agents for Glial Tumors
2005 RFP: New Mechanisms for Preclinical Development and Testing of Agents for Glial Tumors